- Home
- TSHA vs CIVB Comparison
TSHA vs CIVB Comparison
Compare TSHA & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- CIVB
- Stock Information
- Founded
- TSHA 2019
- CIVB 1884
- Country
- TSHA United States
- CIVB United States
- Employees
- TSHA N/A
- CIVB N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- CIVB Major Banks
- Sector
- TSHA Health Care
- CIVB Finance
- Exchange
- TSHA Nasdaq
- CIVB Nasdaq
- Market Cap
- TSHA 262.4M
- CIVB 305.3M
- IPO Year
- TSHA 2020
- CIVB N/A
- Fundamental
- Price
- TSHA $1.24
- CIVB $19.86
- Analyst Decision
- TSHA Strong Buy
- CIVB Buy
- Analyst Count
- TSHA 8
- CIVB 4
- Target Price
- TSHA $6.63
- CIVB $22.67
- AVG Volume (30 Days)
- TSHA 2.4M
- CIVB 44.2K
- Earning Date
- TSHA 05-13-2025
- CIVB 04-24-2025
- Dividend Yield
- TSHA N/A
- CIVB 3.42%
- EPS Growth
- TSHA N/A
- CIVB N/A
- EPS
- TSHA N/A
- CIVB 2.01
- Revenue
- TSHA $8,333,000.00
- CIVB $149,094,000.00
- Revenue This Year
- TSHA N/A
- CIVB $15.59
- Revenue Next Year
- TSHA N/A
- CIVB $5.38
- P/E Ratio
- TSHA N/A
- CIVB $9.88
- Revenue Growth
- TSHA N/A
- CIVB N/A
- 52 Week Low
- TSHA $1.05
- CIVB $13.60
- 52 Week High
- TSHA $4.32
- CIVB $23.70
- Technical
- Relative Strength Index (RSI)
- TSHA 40.35
- CIVB 54.01
- Support Level
- TSHA $1.05
- CIVB $18.80
- Resistance Level
- TSHA $1.36
- CIVB $20.26
- Average True Range (ATR)
- TSHA 0.17
- CIVB 1.01
- MACD
- TSHA -0.01
- CIVB 0.10
- Stochastic Oscillator
- TSHA 25.68
- CIVB 83.57
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.